ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction
Cough is one of the common adverse effects in patients receiving angiotensin-converting enzyme inhibitors (ACEIs).This review presents the current evidence on incidence and Knife Honing Steels mechanisms of cough associated with ACEIs use, and proposes a practical approach for managing the same for optimal cardiovascular (CV) risk reduction.The inc